Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- ASD; ADHD; PDD-NOS; Asperger Syndrome; Autistic Disorder; Hyperactivity; Stimulants; MPH; Guanfacine; Clonidine (1)
- Anxiety, pharmacogenomic testing, anxiety management, first-line anxiety treatment (1)
- Anxiety; pharmacogenomic testing; anxiety management; first-line anxiety treatment; pharmacogenetic testing (1)
- Child mental health (1)
- Culture (1)
-
- Dehydroepiandrosterone, Sulfated Ester, Depression, Dysthymia (1)
- Depression, major depressive disorder, pharmacogenomics, pharmacogenetics, treatment as usual, pharmacotherapy, medication, selective serotonin reuptake inhibitors, antidepressant, psychiatry and Patient Health Questionnaire (PHQ-9) (1)
- Gender differences (1)
- MAT; methadone; buprenorphine; pregnancy; OUD; opioid; addiction; NAS; neonate (1)
- PTSD; STS; divorce rate; mood disorder; therapy; pharmacological regimen (1)
- Parenting (1)
- TSD, STS, divorce rate, mood disorder, therapy, pharmacological regimen (1)
- Publication
- Publication Type
Articles 1 - 9 of 9
Full-Text Articles in Mental and Social Health
Can Early Intervention With Group Therapy Or Individual Therapy Improve The Family Dynamic In Ptsd Patients?, Killian Norton
Can Early Intervention With Group Therapy Or Individual Therapy Improve The Family Dynamic In Ptsd Patients?, Killian Norton
Physician Assistant Scholarly Project Papers
Post-Traumatic Stress Disorder (PTSD) is a mental health disorder that affects an individual directly, while also affecting their family members around them. While PTSD is not directly correlated to the development of Secondary Stress Disorder (STS), PTSD has been shown to lead to increased rates of divorce and mood disorders in children whose parents are diagnosed with PTSD. Children who have grown up with divorced parents, or parents with PTSD, have been shown to have an increased chances of developing mood disorders and risky lifestyle behaviors. The combination of having a parent with PTSD who are also divorced, would likely …
Outcomes In Treatment Of Major Depressive Disorder: Pharmacogenomic Testing Vs. Treatment As Usual, Zachary Horoshak
Outcomes In Treatment Of Major Depressive Disorder: Pharmacogenomic Testing Vs. Treatment As Usual, Zachary Horoshak
Physician Assistant Scholarly Project Papers
The goal of this systematic literature review is to evaluate the efficacy and cost effectiveness of pharmacogenomic testing (PGx) versus treatment as usual (TAU) in the treatment of major depressive disorder (MDD). According to Huang & Lin (2015), MDD is characterized by multiple signs and symptoms consisting of mood, vegetative, cognitive, and even psychotic behaviors that may cause substantial impairment in the functioning and quality of life in an affected individual. This literature review consisted of articles found in PubMed, Cochrane, and PsychINFO which were extensively reviewed. Articles prior to 2008 were excluded due to the ever-changing landscape of PGx …
Managing Anxiety With Pharmacogenomic Testing, Ashley Pommer
Managing Anxiety With Pharmacogenomic Testing, Ashley Pommer
Physician Assistant Scholarly Project Papers
Anxiety affects approximately three to seven percent of the United States population, and nearly 50% of the diagnosed patients fail to respond to first-line treatment regimens (Boland, Duffy, & Meyer 2018). Traditional first-line treatments include medication therapy, cognitive behavioral therapy (CBT), or the combination of both. With such a high initial failure rate, recent studies indicate promising results in managing anxiety with pharmacogenomic testing. Pharmacogenomic testing is allowing providers to prescribe medication based on individual genetic makeup, focusing on how each patient metabolizes certain medications. The purpose of this literature review was to determine if first-line methods or pharmacogenomic testing …
Relationships Between Parent-Reported Parenting, Child-Perceived Parenting, And Children’S Mental Health In Taiwanese Children, Ching-Yu Huang, Yi-Ping Hsieh, April Chiung-Tao Shen, Hsi-Sheng Wei, Jui-Ying Feng, Hsiao-Lin Hwa, Joyce Yen Feng
Relationships Between Parent-Reported Parenting, Child-Perceived Parenting, And Children’S Mental Health In Taiwanese Children, Ching-Yu Huang, Yi-Ping Hsieh, April Chiung-Tao Shen, Hsi-Sheng Wei, Jui-Ying Feng, Hsiao-Lin Hwa, Joyce Yen Feng
Social Work Faculty Publications
The current study examines the relationship between parents’ and children’s reports of parenting and their effects on children’s mental health symptoms. Six hundred and sixty-six parent-child dyads in Taiwan participated in this study. The parents and the children filled out the parenting questionnaires, and the children also reported their general mental health. The results demonstrated that parental-reported and child-perceived parenting were positively correlated, but parents tended to report lower scores on authoritarian parenting and higher scores on Chinese parenting than did their children. There were also significant gender differences: The mothers reported higher authoritative parenting than did the fathers; and …
A Comparison Of Pharmacologic Interventions In Pregnant Women With Opioid Use Disorder, Catherine M. Bopp
A Comparison Of Pharmacologic Interventions In Pregnant Women With Opioid Use Disorder, Catherine M. Bopp
Physician Assistant Scholarly Project Posters
The purpose of this research and systematic literature review is to determine which pharmacotherapeutic agent, methadone or buprenorphine, leads to better outcomes in cases of pregnant mothers with opioid use disorder (OUD). Outcomes considered are maternal compliance, neonatal abstinence syndrome severity, and neonatal length of hospital stay. In the review, PubMed, Clinical Key, Cochrane Database of Systematic Reviews, and DynaMed Plus were searched. Key terms searched were “methadone, buprenorphine, pregnancy”, “opioids, pregnancy”, “neonatal abstinence syndrome” and “medication assisted treatment, pregnancy”. Several studies were excluded, as their study population was not specified to have diagnosed OUD in pregnancy. The drawbacks to …
The Use Of Dehydroepiandrosterone For Treatment Of Depression, Bryan Tipton
The Use Of Dehydroepiandrosterone For Treatment Of Depression, Bryan Tipton
Physician Assistant Scholarly Project Papers
Dehydroepiandrosterone (DHEA) and its sulfated ester (DHEA-S) are important pre-hormones that also have direct neurohormonal effects on the central nervous system. Over the last twenty years, data have revealed that serum DHEA peaks in a person’s mid-20s and steadily declines throughout their lifetime. In addition, women tend to have lower values than men. This is of note because lower serum values tend to be correlated with increased risk of depression, worse depressive symptoms, and increased risk of relapse into depression. A review of literature concerning DHEA’s age related values, its association with depression, and its use in the treatment of …
Can Early Intervention With Group Therapy Or Individual Therapy Improve The Family Dynamic In Ptsd Patients?, Killian Norton
Can Early Intervention With Group Therapy Or Individual Therapy Improve The Family Dynamic In Ptsd Patients?, Killian Norton
Physician Assistant Scholarly Project Posters
Post Traumatic Stress Disorder (PTSD) is a mental health disorder that affects an individual directly, while also affecting their family members around them. While PTSD is not directly correlated to the development of Secondary Stress Disorder (STS), PTSD has been shown to lead to increased rates of divorce and mood disorders in children whose parents are diagnosed with PTSD. Children who have grown up with divorced parents, or parents with PTSD, have been shown to have an increased chances of developing mood disorders and risky lifestyle behaviors. The combination of having a parent with PTSD and being divorced would likely …
Pharmacotherapy For Impulsivity-Hyperactivity Behaviors In Autism Spectrum Disorder, Jenna Katnis
Pharmacotherapy For Impulsivity-Hyperactivity Behaviors In Autism Spectrum Disorder, Jenna Katnis
Physician Assistant Scholarly Project Posters
Hyperactivity is a shared behavior with ASD and Attention Deficit Hyperactivity Disorder (ADHD). Medications such as Methylphenidate (MPH) and α 2-a adrenergic receptor agonists are used to modify hyperactivity behavior in ADHD and thus have been used as management in ASD. A review of literature was done to evaluate the use of medications typically used for ADHD in the use of ASD. The databases searched included PubMED, PsycINFO, Cochrane, and Clinical Key. After reviewing the literature, it was found that both MPH and 2-a adrenergic receptor agonist have a potential role in pharmacotherapy for ASD. MPH may be slightly more …
Managing Anxiety With Pharmacogenomic Testing, Ashley Pommer
Managing Anxiety With Pharmacogenomic Testing, Ashley Pommer
Physician Assistant Scholarly Project Posters
Anxiety affects approximately three to seven percent of the United States population, and nearly 50% of the diagnosed patients fail to respond to first-line treatment regimens (Boland, Duffy, & Meyer 2018). Traditional first-line treatments include medication therapy, cognitive behavioral therapy (CBT), or the combination of both. With such a high initial failure rate, recent studies indicate promising results in managing anxiety with pharmacogenomic testing. Pharmacogenomic testing is allowing providers to prescribe medication based on individual genetic makeup, focusing on how each patient metabolizes certain medications. The purpose of this literature review was to determine if first-line methods or pharmacogenomic testing …